| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/09/2005 | CN1188112C Production process of polymerized micelle with injected medicine and polymerized micelle composition |
| 02/09/2005 | CN1188111C Dry powder compositions having improved dispersivity |
| 02/08/2005 | US6853395 Process and device for inscription of a sheet-like adhesive system of a polymer, especially of a transdermal therapeutic system |
| 02/08/2005 | US6852816 Zwitterionic polymers |
| 02/08/2005 | US6852756 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 02/08/2005 | US6852724 Administering a sustained release drug dosage-form including >5.0% by weight ranolazine in no more than two tablets per dose to maintain ranolazine plasma levels at a >850 ng base/mL for >24 hours; methacrylic acid copolymer binder |
| 02/08/2005 | US6852710 Antitumor agents, anticancer agents |
| 02/08/2005 | US6852709 Biodegradable particles for use in time release agents and gene therapy |
| 02/08/2005 | US6852708 Use of hyaluronic acid and forms to prevent the narrowing of the vascular walls |
| 02/08/2005 | US6852705 DNA vaccines for farm animals, in particular bovines and porcines |
| 02/08/2005 | US6852704 Compositions and methods for reverse gene therapy, wherein a gene therapy vector encoding a gene product (e.g. a protein) which is usually only expressed in cells of an abnormal tissue is delivered to a cell of an animal afflicted with a disease |
| 02/08/2005 | US6852670 Method for manufacturing anion-layered double hydroxide intercalation compounds and compounds produced thereby |
| 02/08/2005 | US6852337 Carvedilol-galenics |
| 02/08/2005 | US6852336 Analgesics; solid dosage form |
| 02/08/2005 | US6852335 Folic acid in solid dosage forms |
| 02/08/2005 | US6852334 Cationic peg-lipids and methods of use |
| 02/08/2005 | US6852314 IFN-β liquid formulations |
| 02/08/2005 | US6852311 Ophthalmic ointments for treating infective eye disease |
| 02/08/2005 | US6852309 Core is mixture of vegetable oil, flavor and artificial sweetener; shell is containing gelatin and pigment |
| 02/08/2005 | US6852308 Iodinated and/or brominated derivatives of aromatic dihydroxy monomers are prepared and polymerized to form radio-opaque polymers. The monomers may also be copolymerized with other dihydroxy monomers. The iodinated and brominated aromatic |
| 02/08/2005 | US6852106 Implantable refillable and ported controlled release drug delivery device |
| 02/08/2005 | US6852104 Programmable insulin pump |
| 02/08/2005 | CA2314313C Stabilized teriparatide solutions |
| 02/08/2005 | CA2223265C Novel laxative compositions and method for making same |
| 02/08/2005 | CA2151383C Stabilized medicinal aerosol solution formulation |
| 02/08/2005 | CA2132711C Liposome encapsulated paclitaxel and a method of using the same |
| 02/08/2005 | CA2120001C Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/08/2005 | CA2097208C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
| 02/06/2005 | CA2476801A1 Method and apparatus for the treatment of obesity |
| 02/03/2005 | WO2005010240A2 Low temperature methods for hermetically sealing reservoir devices |
| 02/03/2005 | WO2005010164A2 Nucleic acid biomaterials and methods of formation and use |
| 02/03/2005 | WO2005010080A1 Temperature-responsive hydrogel |
| 02/03/2005 | WO2005010079A1 Thermosensitive poly (organophosphazenes), preparation method thereof and injectable thermosensitive polyphosphazene hydrogels using the same |
| 02/03/2005 | WO2005010050A1 Hetero type pentamer recombinant vaccine |
| 02/03/2005 | WO2005009738A2 Application of a bioactive agent to a delivery substrate |
| 02/03/2005 | WO2005009737A1 Dot-topography control of dissolution rate of bioactive agents |
| 02/03/2005 | WO2005009475A1 Medicinal preparation containing component originating in bacteruim belonging to the genus clostridium |
| 02/03/2005 | WO2005009474A1 Dry syrup agent containing hardly water soluble drug |
| 02/03/2005 | WO2005009473A1 Antifungal aerosol external preparation |
| 02/03/2005 | WO2005009472A2 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 02/03/2005 | WO2005009458A1 Use of xmp-629 for the treatment of acne |
| 02/03/2005 | WO2005009447A1 Single dose fast dissolving azithromycin |
| 02/03/2005 | WO2005009442A1 Nasal pharmaceutical composition of piribedil |
| 02/03/2005 | WO2005009436A1 Dispersible formulation of an anti-inflammatory agent |
| 02/03/2005 | WO2005009429A1 Compositions containing prodrugs of florfenicol and methods of use |
| 02/03/2005 | WO2005009428A2 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 02/03/2005 | WO2005009426A1 Treatment of heaves |
| 02/03/2005 | WO2005009420A2 Pharmaceutical compositions of short-acting sedative hypnotic agent |
| 02/03/2005 | WO2005009417A1 Composition and method for controlling grug delivery from silicone adhesive blends |
| 02/03/2005 | WO2005009416A1 Modified release compositions for minocycline |
| 02/03/2005 | WO2005009415A2 Novel method for microparticles production |
| 02/03/2005 | WO2005009414A1 Sutained release formulation for venlafaxine hydrochloride |
| 02/03/2005 | WO2005009413A1 Dual drug dosage forms with improved separation of drugs |
| 02/03/2005 | WO2005009412A1 Oral compositions for treatment of diseases |
| 02/03/2005 | WO2005009411A2 Particles containing an active agent in the form of a co-precipitate |
| 02/03/2005 | WO2005009410A2 Pharmaceutical compositions having a swellable coating |
| 02/03/2005 | WO2005009409A2 Controlled release preparations |
| 02/03/2005 | WO2005009408A2 Sustained release dosage forms of anesthetics for pain management |
| 02/03/2005 | WO2005009407A2 Oral pharmaceutical formulations of olanzapine |
| 02/03/2005 | WO2005009406A1 Topical skin care composition containing refined peanut oil |
| 02/03/2005 | WO2005009395A2 Cellulosic fiber containing composition |
| 02/03/2005 | WO2005009386A2 Orally dissolving films |
| 02/03/2005 | WO2005009381A2 Immediate-release formulation of acid-labile pharmaceutical compositions |
| 02/03/2005 | WO2005009380A2 Pharmaceutical formulations |
| 02/03/2005 | WO2005009375A2 Small spherical particles of low molecular weight organic molecules and methods of preparation and use thereof |
| 02/03/2005 | WO2005009371A2 Ultra thin film transdermal/dermal or transmucosal/mucosal delivery system |
| 02/03/2005 | WO2005009368A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009365A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009364A2 Antibiotic product, use and formulation thereof |
| 02/03/2005 | WO2005009357A2 Controlled release compositions |
| 02/03/2005 | WO2005009356A2 Method for the preparation of controlled release formulations |
| 02/03/2005 | WO2005009329A2 Medicament containing 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol with delayed release of active ingredients |
| 02/03/2005 | WO2005009322A2 Delivery system for topical medications |
| 02/03/2005 | WO2005009276A2 Microbial cellulose wound dressing |
| 02/03/2005 | WO2005009225A2 Tissue adhesive sealant |
| 02/03/2005 | WO2005009199A2 Process and machine for automated manufacture of gastro-retentive capsules |
| 02/03/2005 | WO2005002592A3 Stable oral compositions of azithromycin monohydrate |
| 02/03/2005 | WO2004112755B1 Controlled release devices with lumens |
| 02/03/2005 | WO2004098568A3 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer |
| 02/03/2005 | WO2004098390A3 Rf medical device |
| 02/03/2005 | WO2004095946A3 Medical food tablets containing free amino acids |
| 02/03/2005 | WO2004089333A3 A stable benzimidazole formulation |
| 02/03/2005 | WO2004087237A3 Implantable medication delivery device using pressure regulator |
| 02/03/2005 | WO2004087101A3 Oral formulations of cladribine |
| 02/03/2005 | WO2004080399B1 Rapidly absorbing lipophilic skin compositions and uses therefor |
| 02/03/2005 | WO2004078122A3 Invisible patch for active agnet controlled delivery |
| 02/03/2005 | WO2004069203A3 Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 02/03/2005 | WO2004065541A3 Method and apparatus for treating bodily tissues with medicinal substance |
| 02/03/2005 | WO2004047872A3 Treatment of neurodegenerative disease through intracranial delivery of short interfering rna (sirna) |
| 02/03/2005 | WO2004045641A3 Antigen-complexes |
| 02/03/2005 | WO2004041103A3 Oral hygiene system and method of treatment |
| 02/03/2005 | WO2004021985A3 Verifiable absorption drug delivery form based on cyclodextrins |
| 02/03/2005 | WO2003101461A8 Norethindrone sustained release formulations and methods associated therewith |
| 02/03/2005 | WO2003037248A3 Fibrin nanoparticles and uses thereof |
| 02/03/2005 | US20050027283 Mixture of therapeutic agent and polymeric release agent |
| 02/03/2005 | US20050027242 Intradermal delivery device |
| 02/03/2005 | US20050027064 Charge-dynamic polymers and delivery of anionic compounds |
| 02/03/2005 | US20050027019 Aqueous 2,6-diisopropylphenol pharmaceutical compositions |
| 02/03/2005 | US20050027015 Feed containing cysteamine or a salt thereof and a stabilizer such as cyclodextrin; increased milk production in cows |
| 02/03/2005 | US20050027012 In a core, with a film around the core; high dosages; short release time, sufficient mechanical stability, and good tabletting qualities |